Efficacy of bevacizumab-based treatment in early-onset treatment-naïve metastatic colorectal cancer patients: An ARCAD database analysis.

Authors

null

Zhaohui Jin

University of Iowa, Iowa City, IA

Zhaohui Jin , Jesse G. Dixon , Joleen M. Hubbard , Cathy Eng , Christopher Hanyoung Lieu , Jack Fiskum , Leonard B. Saltz , Herbert I. Hurwitz , Alan P. Venook , Hans-Joachim Schmoll , Charles S. Fuchs , J. Randolph Randolph Hecht , Chiara Cremolini , Eduardo Diaz-Rubio , Cornelis J. A. Punt , Niall C. Tebbutt , Volker Heinemann , Takayuki Yoshino , Aimery De Gramont , Qian Shi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

DOI

10.1200/JCO.2022.40.4_suppl.101

Abstract #

101

Poster Bd #

E10

Abstract Disclosures